Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter

Tissue Antigens

Volumn 52, Issue 4, 1998, Pages 359-367

  Uglialoro, A M ^a   Turbay, D ^a,c   Pesavento, P A ^a   Delgado, J C ^a   McKenzie, F E ^b   Gribben, J G ^a   Hartl, D ^b   Yunis, E J ^a   Goldfeld, A E ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

Cambodians; Caucasians; Disease susceptibility; Evolution; HLA; MHC; TNF gene regulation; TNF promoter polymorphisms

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CAUCASIAN; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GENE EXPRESSION; GENE FREQUENCY; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTE; MARKER GENE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION;

EID: 0031719942     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03056.x     Document Type: Article

References (38)

1. Aggarwal BB, Puri RK, ed. Human cytokines: their role in disease and therapy. Cambridge: Blackwell Science, 1995.
2. Garcia I, Miyazaki Y, Araki K et al. Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur J Immunol 1995: 25: 2401-7.
3. Flynn JL, Goldstein MM, Chan J et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995: 2: 561-72.
4. Lucas R, Juilliard P, Redard M et al. Lack of TNF receptor 2 but not of TNFR1 protects mice from experimental murine cerebral malaria. Eur Cytokine Netw 1996: 7: 247.
5. Goldfeld A, Tsai EY. TNF-alpha and genetic susceptibility to parasitic disease. Exp Parasitol 1996: 84: 300-3.
6. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1992: 1: 353.
7. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994: 39: 150-4.
8. Zimmerman PA, Guderian RH, Nutman TB. A new TNFA promoter allele identified in South American Blacks. Immunogenetics 1996: 44: 485-6.
9. Brinkman BMN, Giphart MJ, Verhoef A et al. Tumor necrosis factor alpha -308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome. Hum Immunol 1994: 41: 259-66.
10. Brinkman BMN, Kaijzel EL, Huizinga TWJ, Giphart MJ, Breedveld FC, Verweij CL. Detection of a novel c-insertion polymorphism within the human tumor necrosis factor alpha gene. Hum Genetics 1995: 96: 493.
11. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF alpha promoter is not associated with type II diabetes mellitus. Biochem Biophys Res Commun 1995: 211: 833-9.
12. Goldfeld AE, Doyle C, Maniatis T. Human tumor necrosis factor-α gene regulation by virus and lipopolysaccharide. Proc Natl Acad Sci U S A 1990: 87: 9769-73.
13. Goldfeld AE, Strominger JL, Doyle C. Human tumor necrosis factor-α gene regulation in phorbol ester stimulated B and T cell lines. J Exp Med 1991: 174: 73-81.
14. Goldfeld AE, McCaffrey PG, Strominger JL, Rao A. The human tumor necrosis factor-α gene is regulated by a novel cyclosporin-sensitive promoter element in activated T cells. J Exp Med 1993: 178: 1365-79.
15. Tsai EY, Jain J, Pesavento PA, Rao A, Goldfeld AE. TNF-α gene regulation in activated T cells involves ATF-2/Jun and NFATp. Mol Cell Biol 1996: 16: 459-67.
16. Tsai EY, Yie J, Thanos D, Goldfeld AE. Cell-type specific regulation of the human tumor necrosis factor-α gene in B cells by NFATp and ATF-2/Jun. Mol Cell Biol 1996: 16: 5232-44.
17. Granja CB, Salazar M, Yunis EJ. Population genetics and human leukocyte antigen polymorphism. In: Tilney NL, Strom TB, Paul LC, ed. Transplantation biology. Philadelphia (PA): Lippincott-Raven Publishers, 1996: 311-25.
18. Gribben JG, Freedman AS, Newberg D et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B cell lymphoma. N Eng J Med 1991: 325: 1525-33.
19. Goldfeld AE, Delgado JC, Sok T et al. Association of an HLA-DQ allele with clinical tuberculosis. J Am Med Assoc 1998: 279: 226-8.
20. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
21. Yang SY, Milford E, Hammerling U, Dupont B. Description of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system: the B-cell line panel designed for the Tenth International Histocompatibility Workshop. In: Dupont B, ed. Immunobiology of HLA. New York: Springer-Verlag, 1989: 11-19.
22. Charron D, ed. Genetic diversity of HLA functional and medical implication. Paris, France: EDK, 1997.
23. Salazar M, Yunis JJ, Delgado MB, Bing D, Yunis EJ. HLA-DQB1 allele typing by a new PCR-RFLP method: correlation with a PCR-SSO method. Tissue Antigens 1992: 40: 116-23.
24. Turbay D, Lieberman J, Alper CA et al. Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups. Blood 1997: 89: 4167-74.
25. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993: 177: 557-60.
26. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993: 16: 180-6.
27. Alper CA, Awdeh ZL, Yunis EJ. Complotypes and extended haplotypes in laboratory medicine. Complement Inflamm 1989: 6: 8-18.
28. Dupont B, Pollack MS, Levine MS, O'Neill GJ, Hawkins BR, New MI. Joint report. Congenital adrenal hyperplasia. In: Terasaki PJ, ed. Histocompatibility Testing: Los Angeles: UCLA Press, 1980: 693-706.
29. Fleishnick E, Raum D, Alosco SM et al. Extended MHC haplotypes in 21-hydroxylase-deficiency congenital hyperplasia: shared genotypes in unrelated patients. Lancet 1983: 1: 152-6.
30. Awdeh ZL, Raum D, Yunis EJ, Aper CA. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc Natl Acad Sci U S A 1983: 80: 259-63.
31. Gruen JR, Weissman SM. Evolving views of the major histocompatibility complex. Blood 1997: 90: 4252-65.
32. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNF-α) -308 promoter polymorphism in TNF-α gene regulation. J Inflamm 1996: 46: 32-6.
33. Stuber F, Udalova IA, Book M et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996: 46: 42-7.
34. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997: 94: 3195-9.
35. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997: 4: 391-9.
36. Drouet C, Shakhov AN, Jongeneel CV. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor alpha promoter in primary macrophages. J Immunol 1991: 147: 1694-700.
37. Jacob CO, Fronek Z, Lewis G, Koo M, Hansen JA, McDevitt HO. Heritable histocompatibility complex class II-associated differences in production of tumor necrosis factor-α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci U S A 1990: 87: 1233-7.
38. Garcia-Merino A, Alper CA, Usuku K et al. Tumor necrosis factor microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Hum Immunol 1996: 50: 11-21.